Display options
Cite
McMurray JJV, Packer M. How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine. Circulation. 2020;143(9):875-877doi: 10.1161/CIRCULATIONAHA.120.052926.
McMurray, J. J. V., & Packer, M. (2021). How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine. Circulation, 143(9), 875-877. https://doi.org/10.1161/CIRCULATIONAHA.120.052926
McMurray, John J V, and Packer, Milton. "How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine." Circulation vol. 143,9 (2021): 875-877. doi: https://doi.org/10.1161/CIRCULATIONAHA.120.052926
McMurray JJV, Packer M. How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine. Circulation. 2021 Mar 02;143(9):875-877. doi: 10.1161/CIRCULATIONAHA.120.052926. Epub 2020 Dec 30. PMID: 33378214.
Copy Download .nbib Format: NLM
Share it on

Circulation. 2021 Mar 02;143(9):875-877. doi: 10.1161/CIRCULATIONAHA.120.052926. Epub 2020 Dec 30.

How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine.

Circulation

John J V McMurray, Milton Packer

Affiliations

  1. British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Scotland, United Kingdom (J.J.V.M.).
  2. Baylor University Medical Center, Dallas, TX (M.P.).
  3. Imperial College, London, United Kingdom (M.P.).

PMID: 33378214 DOI: 10.1161/CIRCULATIONAHA.120.052926

[No abstract available.]

Keywords: adrenergic beta-antagonists; aldosterone; angiotensin converting enzyme inhibitors; heart failure; neprilysin; receptors, mineralocorticoid; sodium-glucose transport proteins

Publication Types

Grant support